Back to the archive
10/10/2018| 10 October, World Mental Health Day

Depression seems an increasing threat in recent times and amongst new generations: international and national data indicate that depressive and anxiety disorders are the most common and widespread mental-health conditions. It is estimated that more than 300 million people suffer from depression around the world, and over 260 million have anxiety disorders.

In Europe, 40 million citizens suffer with depression, whilst in Italy around 10 million suffer from depression and/or anxiety during their lifetime. Around 5% of the adult population suffers from depressive syndromes each year in Italy, almost 3 million individuals.

Depression has a huge impact on society and productivity at work: 25% of total working days “lost” are linked to depression, and 25-50% of sufferers display an evident decrease in productivity at work.

Another significant current topic is the importance of early diagnosis, above all for depression. This is particularly important in teenagers and children, and this was one of the most widely discussed topics during the recent ECNP neuropsychopharmacology conference.

These findings, along with many others, are the outcome of recent studies carried out by the WHO regarding the key theme of World Mental Health Day, on 10 October 2018.

“Today we are reminded of just how important our work is at Angelini, ensuring that patients receive increasingly effective treatments and drugs” – stated Gianluigi Frozzi, CEO Pharma Angelini “and just how much our efforts are aimed in the right direction for all aspects of the pathology in the strictest sense, its diagnosis also in younger age groups, and the many different implications from a family, social, economic and worklife perspective.”

Back to the archive